![]() |
市场调查报告书
商品编码
1817969
2032 年微生物组健康补充剂市场预测:按产品类型、形式、来源、应用、最终用户和地区进行的全球分析Microbiome Wellness Supplements Market Forecasts to 2032 - Global Analysis By Product Type (Probiotics, Prebiotics, Synbiotics and Postbiotics), Form, Source, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球微生物组健康补充剂市场预计在 2025 年达到 6 亿美元,到 2032 年将达到 23 亿美元,预测期内的复合年增长率为 20.9%。
微生物组健康补充剂是一种营养配方,旨在支持人体肠道微生物组,增强消化功能、免疫力和整体健康。这些产品通常含有益生菌、益生元、合益素和后生元,以平衡消化道中的有益菌丛。优化微生物多样性有助于改善营养吸收、减少发炎和改善情绪调节。这些补充剂通常以胶囊、粉末或机能饮料的形式出售,将微生物组科学融入日常健康和保健方案中。
根据美国国立卫生研究院人类微生物组计划,人类肠道微生物组可以影响从免疫功能到情绪的一切,为有针对性的益生菌菌株创造了巨大的市场。
益生菌和益生元的需求不断成长
益生菌和益生元因其对肠道健康、免疫力和整体健康的益处而受到日益增长的需求的强劲推动,推动了市场的发展。受文明病和消化器官系统问题的影响,越来越多的消费者将微生物组补充剂作为预防性健康措施。越来越多的临床证据支持其功效,推动了全球消费者的信任和采用。添加益生菌的机能性食品和饮料正在进一步提高人们的认知度。消费者对此类肠道友善解决方案的日益增长的偏好,仍然是推动已开发经济体和新兴经济体市场成长的核心因素。
缺乏标准化的功效测试方法
一个主要阻碍因素是缺乏全球标准化的方法来检验微生物组健康补充剂的功效。临床试验结果的差异以及不同菌株之间的差异,使得消费者和医疗保健提供者难以比较产品。监管机构难以製定一致的指导方针,导致标籤和声明含糊不清。缺乏统一的基准会降低信任度,并减缓市场渗透。在健全且普遍接受的测试标准出台之前,微生物组补充剂的发展可能会面临重大障碍。
开发个人化微生物组解决方案
个人化微生物组补充剂在基因组学、人工智慧和诊断工具的推动下,蕴含着巨大的机会。各公司正在根据个人肠道微生物组特征开发定製配方,以提供更佳功效和更有针对性的健康结果。个人化健康理念契合消费者对客製化医疗保健解决方案的需求,尤其是在高端消费者群体中。与家用微生物组检测套组的整合,进一步提升了产品的可近性。随着精准营养的日益普及,个人化补充剂的开发将彻底改变市场格局,为创新者创造高价值机会。
与天然发酵食品的竞争
优格、Kefir、酸菜和康普茶等天然发酵食品日益流行,为市场带来了显着的威胁。这些食品以熟悉、方便的方式提供益生菌益处,无需补充剂。许多消费者认为这些食品更实惠、更天然,从而减少了对补充剂的依赖。此外,亚洲和欧洲等地区的传统饮食习惯已经强调发酵食品,这加剧了竞争。这些文化和成本替代风险对寻求大规模应用的补充剂製造商构成了持续的挑战。
新冠疫情对微生物组健康补充剂市场产生了重大影响,引发了人们对增强免疫力解决方案的兴趣。越来越多的消费者选择益生菌、益生元和合合益素来增强自身抵抗感染疾病的能力。随着实体零售店的关闭,电商通路的销售额激增。然而,供应链中断和临床试验的延迟暂时阻碍了产品的上市。即使在疫情过后,由于消费者更加重视肠道健康和免疫力,需求依然强劲。总体而言,新冠疫情起到了催化剂的作用,将微生物组补充剂转变为具有长期市场相关性的主流健康产品。
益生菌市场预计将在预测期内占据最大份额
由于消费者强烈意识到益生菌对消化器官系统和免疫系统的益处,因此预计益生菌细分市场将在预测期内占据最大市场份额。益生菌补充剂拥有广泛的临床支持,使其成为微生物组健康领域最值得信赖的类别。益生菌补充剂以胶囊、药片和机能性食品的形式广泛供应。医疗保健宣传活动和医疗专业人士的推荐进一步推动了益生菌的普及。由于益生菌产品在零售店和线上平台的便捷获取,益生菌仍保持主导。
预计预测期内粉末细分市场将以最高复合年增长率成长
预计粉末市场将在预测期内实现最高成长率,这得益于对便捷多功能补充剂形式日益增长的需求。粉状微生物组产品可以轻鬆添加到饮料、冰沙和食品中,从而提高日常依从性。与片剂和胶囊相比,它们还提供可自订的剂量和更快的吸收速度。此外,口味和稳定性方面的创新增强了消费者的吸引力。随着年轻一代更青睐功能性营养剂型,粉状补充剂被定位为成长最快的细分市场,既满足了便捷的生活方式,也满足了人们对健康的期望。
预计亚太地区将在预测期内占据最大的市场份额,这得益于其对发酵食品的文化认同以及传统的肠道健康实践。日益增强的健康意识和都市化正在推动日本、中国和印度等国家对微生物组补充剂的需求。不断壮大的中产阶级和政府对健康计画的支持进一步推动了微生物组补充剂的采用。本土企业正在利用阿育吠陀、传统中医和自然疗法的融合。文化认同与经济成长的结合,确保了亚太地区在全球市场的主导地位。
在预测期内,北美预计将呈现最高的复合年增长率,这得益于消费者对个人化营养和预防性医疗保健的浓厚兴趣。该地区受益于先进的科研基础设施、日益增长的慢性病患病率以及强大的购买力。电子商务和专业保健品零售商正在确保微生物组补充剂的广泛应用。补充剂製造商和生物技术公司之间日益增长的伙伴关係将进一步推动技术创新。随着消费者寻求有证据支持的客製化肠道和免疫健康解决方案,北美正成为这个充满活力的市场中成长最快的地区。
According to Stratistics MRC, the Global Microbiome Wellness Supplements Market is accounted for $0.6 billion in 2025 and is expected to reach $2.3 billion by 2032 growing at a CAGR of 20.9% during the forecast period. Microbiome wellness supplements are nutritional formulations aimed at supporting the human gut microbiota to enhance digestion, immunity, and overall health. These products typically contain probiotics, prebiotics, synbiotics, or postbiotics that regulate the balance of beneficial bacteria in the gastrointestinal tract. By optimizing microbial diversity, they contribute to better nutrient absorption, reduced inflammation, and improved mood regulation. Often available as capsules, powders, or functional beverages, these supplements integrate microbiome science into accessible, daily health and wellness regimens.
According to the NIH's Human Microbiome Project, the human gut microbiome can influence everything from immune function to mood, creating a vast market for targeted probiotic strains.
Growing demand for probiotics and prebiotics
The market is strongly driven by rising demand for probiotics and prebiotics, recognized for their benefits in gut health, immunity, and overall wellness. Consumers increasingly turn to microbiome supplements as preventive health measures, influenced by lifestyle diseases and digestive issues. Expanding clinical evidence supports their efficacy, boosting trust and adoption globally. Functional foods and beverages incorporating probiotics further amplify awareness. This growing consumer inclination toward gut-friendly solutions continues to be the core driver fueling market growth across both developed and emerging economies.
Lack of standardized efficacy testing methods
A major restraint lies in the absence of globally standardized methods to validate the efficacy of microbiome wellness supplements. Variability in clinical trial outcomes and strain-specific differences make it difficult for consumers and healthcare providers to compare products. Regulatory bodies struggle to establish consistent guidelines, creating ambiguity in labeling and claims. This lack of uniform benchmarks diminishes trust and slows market penetration. Until robust, universally accepted testing standards are implemented, the growth of microbiome supplements may face significant hurdles.
Development of personalized microbiome solutions
Personalized microbiome supplements present a significant opportunity, driven by advancements in genomics, AI, and diagnostic tools. Companies are developing tailored formulations based on an individual's gut microbiota profile, offering higher efficacy and targeted health outcomes. Personalized wellness aligns with consumer demand for customized healthcare solutions, especially among premium buyers. Integration with at-home microbiome testing kits further enhances accessibility. As precision nutrition gains traction, the development of individualized supplements is set to revolutionize the market, creating high-value opportunities for innovators.
Competition from naturally fermented foods
The market faces notable threats from the growing popularity of naturally fermented foods such as yogurt, kefir, sauerkraut, and kombucha. These foods offer probiotic benefits in familiar, convenient formats without requiring supplementation. Many consumers perceive them as more affordable and natural, reducing dependency on supplements. Additionally, traditional dietary habits in regions like Asia and Europe already emphasize fermented foods, intensifying competition. This cultural and cost-based substitution risk poses a persistent challenge to supplement manufacturers seeking mass adoption.
The COVID-19 pandemic significantly influenced the microbiome wellness supplements market, spurring interest in immunity-boosting solutions. Consumers increasingly turned to probiotics, prebiotics, and synbiotics to strengthen resilience against infections. Sales surged through e-commerce channels as lockdowns disrupted physical retail. However, supply chain interruptions and clinical trial delays temporarily hindered product launches. Post-pandemic, demand remains strong as consumers continue prioritizing gut health and immunity. Overall, COVID-19 acted as a catalyst, transforming microbiome supplements into mainstream wellness products with long-term market relevance.
The probiotics segment is expected to be the largest during the forecast period
The probiotics segment is expected to account for the largest market share during the forecast period, resulting from strong consumer awareness of their digestive and immune benefits. Probiotic supplements enjoy extensive clinical backing, making them the most trusted category within microbiome wellness. They are widely incorporated in capsules, tablets, and functional foods, ensuring broad accessibility. Marketing campaigns and endorsements by healthcare professionals further enhance adoption. With robust product availability across retail and online platforms, probiotics maintain leadership as the largest and most established market segment.
The powders segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the powders segment is predicted to witness the highest growth rate, propelled by rising demand for convenient, versatile supplement formats. Powdered microbiome products can be easily incorporated into beverages, smoothies, or foods, improving daily compliance. They offer customizable dosages and faster absorption compared to tablets or capsules. Additionally, innovations in flavoring and stability enhance consumer appeal. With younger demographics favoring functional nutrition formats, powdered supplements are positioned as the fastest-growing segment, meeting both lifestyle convenience and health-focused expectations.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to its cultural familiarity with fermented foods and traditional gut health practices. Countries such as Japan, China, and India are experiencing rising demand for microbiome supplements due to growing health awareness and urbanization. Expanding middle-class populations and supportive government health initiatives further stimulate adoption. Local players capitalize on Ayurveda, TCM, and natural remedies integration. This combination of cultural acceptance and economic growth secures Asia Pacific's dominance in the global market.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with strong consumer interest in personalized nutrition and preventive healthcare. The region benefits from advanced research infrastructure, rising chronic disease prevalence, and high purchasing power. E-commerce and specialty health retailers ensure widespread availability of microbiome supplements. Growing partnerships between supplement manufacturers and biotech firms further drive innovation. As consumers demand evidence-backed, customized solutions for gut and immune health, North America emerges as the fastest-expanding region in this dynamic market.
Key players in the market
Some of the key players in Microbiome Wellness Supplements Market include Nestle S.A., Danone S.A., Yakult Honsha Co., Ltd., Chr. Hansen Holding A/S, BioGaia AB, Probi AB, International Flavors & Fragrances Inc. (IFF), Kerry Group plc, Ingredion Incorporated, Glanbia plc, Novozymes A/S, Archer-Daniels-Midland Company (ADM), DuPont de Nemours, Inc., Lifeway Foods, Inc., Morinaga Milk Industry Co., Ltd., Meiji Holdings Co., Ltd., Herbalife Nutrition Ltd., and Reckitt Benckiser Group plc.
In Aug 2025, Chr. Hansen Holding A/S introduced "Wellbre(TM) Daily," a new range of probiotic capsules featuring a multi-strain formulation with targeted delivery technology to ensure a higher rate of bacterial survival through the digestive tract.
In July 2025, Yakult Honsha Co., Ltd. announced the "Yakult 1000 Chewable," a new delivery format of its flagship probiotic containing 100 billion CFUs of Lacticaseibacillus paracasei strain Shirota, designed for on-the-go convenience and targeted stress relief.
In June 2025, DuPont de Nemours, Inc. commercialized "HOWARU(R) Premium Mood," a clinically-studied probiotic supplement containing a unique combination of strains shown to positively influence the gut-brain axis and support emotional well-being.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.